- Udyam number
- UDYAM-RJ-10-0005174

About Nexnos Pharma Limited
Data last updated:
Nexnos Pharma Limited is a public limited company based in Chittorgarh, Rajasthan, India. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 14 August 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24100RJ2007PLC024845. Its GSTIN is 08AAGCA4692M1Z5 (Rajasthan). The company holds 3 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹1.91 Cr. It was formerly known as Asnani Brokers Private Limited. It is led by directors including Kamal Asnani and Vinod Asnani.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 103 Pratap Nagar Sindhi Colony, Chittorgarh, Rajasthan, India – 312001.
As per the financials filed for FY 2025, the company reported a revenue of ₹36.91 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹3.7 Cr (net margin 10%) and EBITDA of ₹5.16 Cr (EBITDA margin 14%). Revenue has grown at a compounded annual rate (CAGR) of 248% over three years and 331% over five years.
As per MCA filings, the company has open charges of ₹12 Cr and satisfied charges of ₹12 Cr on record.
Nexnos Pharma Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-RJ-10-0005174). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website asnanionline.com.
Company details
Name history
Nexnos Pharma has undergone 2 name changes throughout its history. The company was previously known as Asnani Brokers Private Limited, and Nexnos Pharma Limited. The current legal name is Nexnos Pharma Limited.
| Company Name | Status |
|---|---|
| Nexnos Pharma Limited | Current |
| Asnani Brokers Private Limited | Previous |
CIN history
Nexnos Pharma has 3 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24100RJ2007PLC024845, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24100RJ2007PLC024845 | Current |
| U67120RJ2007PTC024845 | Previous |
| U74110RJ2007PTC024845 | Previous |
| U24100RJ2007PTC024845 | Previous |
Recognitions & Rankings of Nexnos Pharma
Contact details
Nexnos Pharma Limited's registered office is in Chittorgarh, Rajasthan.
- Social Media
- Registered Address103 Pratap Nagar Sindhi Colony, Chittorgarh, Rajasthan, India – 312001
- IndustryHealthcare, Medical Equipment Retail & Distribution
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Nexnos Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Nexnos Pharma Limited, buy the company report.
Financials of Nexnos Pharma Limited
FY 2025 filings availableNexnos Pharma Limited reported revenue of ₹36.91 Cr (up 187% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 331% over five years, including 187% growth in the latest year. EBITDA rose 151% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.16 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.7 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 14% | ||||
| Net Profit Margin | 10% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nexnos Pharma Limited, buy the company report.
Board of directors of Nexnos Pharma Limited
Nexnos Pharma has 5 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kamal Asnani | Director | 14 Aug 2007 | 19 Years 3 Months | Current |
| Vinod Asnani | Director | 14 Aug 2007 | 19 Years 3 Months | Current |
| Rajesh Peswani Also directs: Euro Exports Private Limited | Director | 20 Mar 2024 | 2 Years 7 Months | Current |
| Rameshchandra Also directs: Remescan Healthcare Private Limited | Director | 03 May 2023 | 3 Years 6 Months | Current |
| Ashish Kumar Agrawal | Director | 03 May 2023 | 3 Years 6 Months | Current |
Peer comparison
Nexnos Pharma Limited is compared with the 5 companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ranish Impex Private Limited | ₹37.1 Cr (FY 2024) | 16.0% | Mumbai, Maharashtra, India | |||
| Spectra Therapeutics Private Limited | ₹37.02 Cr (FY 2025) | 20.0% | Ahmedabad, Gujarat, India | |||
| Imaging Products (India) Private Limited | ₹36.97 Cr (FY 2024) | -6.0% | Chennai, Tamil Nadu, India | |||
| Nexnos Pharma Limitedthis company | ₹36.91 Cr (FY 2025) | ₹3.7 Cr | 10% | 187.0% | Chittorgarh, Rajasthan, India | |
| H Jules & Company Ltd | ₹36.88 Cr (FY 2023) | 19.0% | Nagpur, Maharashtra, India | |||
| Genpharmasec Limited | ₹36.78 Cr (FY 2025) | 18.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Nexnos Pharma Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 19 Jun 2024 | 100936082 | Others | ₹12 Cr | Satisfied |
To see the full charge records of Nexnos Pharma Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Nexnos Pharma Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nexnos Pharma Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Nexnos Pharma has 3 GST registrations: 2 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAGCA4692M1Z5 | Rajasthan | Active | 01 Jul 2017 |
| 27AAGCA4692M1Z5 | Maharashtra | Active | 01 Jun 2023 |
To see the full GST registrations and return filing status of Nexnos Pharma Limited, buy the company report.
Recent activity
Nexnos Pharma Limited has 6 board changes on record since 2007: 5 appointments and 1 cessation. The latest: Rameshchandra ceased to be Director on 29 Mar 2024.
Frequently asked questions
Nexnos Pharma is an active public limited company based in Chittorgarh, Rajasthan, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 14 August 2007 (19+ years old) and is registered under CIN U24100RJ2007PLC024845.
Nexnos Pharma has 5 current directors:
- Kamal Asnani - Director
- Vinod Asnani - Director
- Rajesh Peswani - Director
- Rameshchandra - Director
- Ashish Kumar Agrawal - Director
The latest financial statements of Nexnos Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Nexnos Pharma is 08AAGCA4692M1Z5, registered in Rajasthan. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 27AAGCA4692M1Z5 (Maharashtra).
The CIN (Corporate Identification Number) of Nexnos Pharma is U24100RJ2007PLC024845. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nexnos Pharma was incorporated on 14 August 2007, making it 19+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Nexnos Pharma by revenue are Ranish Impex Private Limited, Spectra Therapeutics Private Limited, Imaging Products (India) Private Limited, H Jules & Company Ltd, Genpharmasec Limited, all in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Rameshchandra ceased to be Director on 29 Mar 2024. Rajesh Peswani was appointed as Director on 20 Mar 2024. Ashish Kumar Agrawal was appointed as Director on 03 May 2023. Nexnos Pharma has 6 board changes on record in total.
Yes, Nexnos Pharma is registered as an MSME under Udyam registration (number: UDYAM-RJ-10-0005174).
Nexnos Pharma can be reached through the website asnanionline.com. Its registered office is in Chittorgarh, Rajasthan, India.
The registered office of Nexnos Pharma is at 103 Pratap Nagar Sindhi Colony, Chittorgarh, Rajasthan, India – 312001.

